Cardiol Therapeutics share price logo

Cardiol Therapeutics

NASDAQ: CRDL

$1.12

-0.04

(-3.85%)

as on

Cardiol Therapeutics Stock Performance

as on October 31, 2026 at 6:59 am IST

  • Day's Low

    Day's High

    $1.10
    $1.17
    downward going graph

    1.79%

    Downside

    4.46%

    Upside

    downward going graph
  • 52 Week's Low

    52 Week's High

    $0.88
    $2.34
    downward going graph

    21.43%

    Downside

    108.93%

    Upside

    downward going graph

Cardiol Therapeutics share price movements today

Previous Close
$1.17
Open
$1.17
Volume
914.1K
Market Cap
$142.2M
Day's Low - High
$1.10 - $1.17
52 Week Low - High
$0.88 - $2.34

Cardiol Therapeutics Historical Returns

1 Month Return
-29.52 %
3 Month Return
-3.31 %
1 Year Return
+ 6.36 %
3 Year Return
+ 42.68 %
5 Year Return
-67.68 %

Cardiol Therapeutics Stock Fundamentals & Key Indicators

Check Cardiol Therapeutics market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$142.2M

EPS (TTM)

-0.3441

Dividend Yield

0.00%

Quarterly Earnings Growth YOY

0.00%

PE Ratio (TTM)

-4.88

Industry PE ratio

-9.84

PEG Ratio

-0.14

EBITDA

-35.6M

Revenue (TTM)

-

Profit Margin

0.00%

Return On Equity TTM

-180.13%

Cardiol Therapeutics vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Cardiol Therapeutics with its industry peers.

Company
Analyst View
Market Cap
5 Years Return %PE RatioProfit Margin %Dividend Yield %
Buy$142.2M-67.68%-4.880.00%0.00%
Buy$42.5BNA64.6447.54%1.06%
StrongBuy$25.2B211.14%19.4086.14%0.00%
Buy$21.5B40.60%-52.0034.83%2.56%
Buy$43.8BNA20.6265.57%1.24%

Stock Returns calculator for Cardiol Therapeutics Stock including INR - Dollar returns

The Cardiol Therapeutics stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Impact: The bonus return you make when the US Dollar rises against the Rupee; calculated on the full amount you walk away with, not just what you invested in.

Investment Value

₹1,00,000

  • 1Y

  • 3Y

  • 5Y

Cardiol Therapeutics investment value today

Current value as on today

₹1,09,076

Returns

₹9,076

(+9.08%)

Returns from Cardiol Therapeutics Stock

₹1,818 (+1.82%)

Dollar Impact

₹7,258 (+7.26%)

Analyst Recommendation on Cardiol Therapeutics Stock

Based on 2 analysts

BUY

100.00%

Buy

0.00%

Hold

0.00%

Sell

Based on 2 analysts, 100% of analysts recommend a 'BUY' rating for Cardiol Therapeutics. Average target price of $8.59

Cardiol Therapeutics Share Price Target

Get share price movements and forecasts by analysts on Cardiol Therapeutics.

What analysts predicted

86.96%UPSIDE

Target Price

$8.59

Current Price

$1.12

Analyzed by

2 Analysts

High

$11

Target

$8.59

Low

$10

Cardiol Therapeutics target price $8.59, a slight upside of 86.96% compared to current price of $1.12. According to 2 analysts rating.

Indian Investors' Interest in Cardiol Therapeutics Stock

Search interest for Cardiol Therapeutics Stock has decreased by -14% in the last 30 days, reflecting a downward trend in search activity.

Time period: to

Change:-14% versus previous 30 day period

Cardiol Therapeutics Quarterly Profit & Loss

All numbers in Millions USD

Jun 2023
Sep 2023
Mar 2024
Jun 2024
Sep 2024
Mar 2025
Jun 2025
Sep 2025
Mar 2026
Jun 2026
Total Revenue
-
-
-
-
-
-
-
-
-
-
Gross Profit
0
0
0
0
-
-
0
-
0
0
Operating Income
-4
-8
-8
-7
-14
-8
-7
-10
-9
-7
EBITDA
-6
-7
-8
-7
-13
-8
-7
-9
-9
-7
Interest Expense
-
-
-
-
-
-
-
-
-
-
Depreciation
0
0
0
0
0
0
0
0
0
0
Income Before Tax
-7
-5
-9
-6
-12
-8
-8
-9
-10
-6
Income Tax Expense
1
-1
0
-
-
-
-
-
-
-
Net Income
-7
-5
-9
-6
-12
-8
-8
-9
-10
-6
Net Profit Margin
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%

Cardiol Therapeutics Annual Profit & Loss

All numbers in Millions USD

Dec 2017
Dec 2018
Dec 2019
Mar 2021
Dec 2021
Dec 2022
Mar 2024
Mar 2025
Mar 2026
Total Revenue
-
-
-
-
0
-
-
-
-
Gross Profit
0
0
0
0
0
0
0
0
-
Operating Income
-1
-7
-13
-20
-45
-50
-29
-40
-34
EBITDA
-1
-15
-13
-20
-38
-30
-27
-36
-34
Interest Expense
0
0
0
-
-
-
-
-
-
Depreciation
0
0
0
0
0
0
0
0
0
Income Before Tax
-1
-15
-13
-20
-31
-30
-28
-36
-33
Income Tax Expense
-
-
0
0
-6
-19
-
-
-
Net Income
-1
-15
-13
-20
-24
-11
-28
-36
-33
Net Profit Margin
0.00%
0.00%
0.00%
0.00%
100.00%
0.00%
0.00%
0.00%
0.00%

Cardiol Therapeutics Quarterly Cash Flow

All numbers in Millions USD

Jun 2023
Sep 2023
Mar 2024
Jun 2024
Sep 2024
Mar 2025
Jun 2025
Sep 2025
Mar 2026
Jun 2026
Net Income
-7
-5
-9
-6
-12
-8
-8
-9
-10
-6
Operating Cash Flow
-5
-3
-6
-4
-7
-7
-4
-6
-7
-4
Investing Cash Flow
0
0
0
0
0
0
0
0
0
0
Financing Cash Flow
0
0
0
0
0
0
0
0
13
2
Change in Cash
-4
-4
-6
-4
-8
-7
-5
-6
6
-1

Cardiol Therapeutics Annual Cash Flow

All numbers in Millions USD

Dec 2017
Dec 2018
Dec 2019
Mar 2021
Dec 2021
Dec 2022
Mar 2024
Mar 2025
Mar 2026
Net Income
-1
-15
-13
-20
-31
-30
-28
-36
-33
Operating Cash Flow
-1
-10
-11
-9
-23
-27
0
-25
-23
Investing Cash Flow
0
0
0
0
0
0
0
0
0
Financing Cash Flow
3
25
2
16
93
0
0
18
15
Change in Cash
2
14
-9
7
69
-24
-24
-4
-9

Global Institutional Holdings in Cardiol Therapeutics

Check out the Institutions with significant holdings in Cardiol Therapeutics.

Funds
Holdings
State Street
0.08%
Fidelity Concord Street Trust
0.02%

Cardiol Therapeutics News & Key Events

  • img

    Today's Timeline - 23 September

    Wed, 04:27 PM

    -

    Cardiol Therapeutics expands Phase III MAVERIC trial enrollment to 150 patients after achieving initial target of 110 patients ahead of schedule.

Insights on Cardiol Therapeutics

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

  • imgNO EFFECT

    Against Peers

    img

    In the last 1 year, Viatris Inc. Common Stock has given 85.3% return, outperforming this stock by 81.8%

  • imgNO EFFECT

    Against Peers

    img

    In the last 3 years, SANDOZ GROUP AG SPONSORED ADS Switzerland has given 115.7% return, outperforming this stock by 74.7%

  • imgNEGATIVE IMPACT

    Price Dip

    img

    In the last 1 month, CRDL stock has moved down by -29.5%

About Cardiol Therapeutics

Cardiol Therapeutics Inc. operates as a clinical-stage life sciences company, primarily engaged in the discovery and advancement of treatments designed to combat fibrosis and inflammation within the context of cardiovascular diseases. Its flagship product, CardiolRx, is currently undergoing a significant Phase II/III international clinical trial. This extensive study is randomized, double-blind, and placebo-controlled, evaluating CardiolRx's efficacy and safety as a heart-protective therapy to mitigate cardiovascular and respiratory issues in individuals hospitalized with COVID-19. Concurrently, the trial also assesses CardiolRx's role in addressing acute myocarditis. Beyond this, the company is developing an injectable, subcutaneous formulation of CardiolRx, intended to target cardiac scarring and inflammation that contribute to the development and worsening of heart failure. Established in 2017, Cardiol Therapeutics Inc. is based in Oakville, Canada.
OrganisationCardiol Therapeutics
Headquarters2265 Upper Middle Road East, Oakville, ON, L6H 0G5, CA
IndustryDrug Manufacturers - Specialty & Generic
CEODavid G. Elsley

Key Management of Cardiol Therapeutics

Name

Title

Trevor Burns

Investor Relations

Mr. John A. Geddes BSCPT, MBA

Vice President of Corporate Development

Mr. David G. Elsley MBA

President, CEO & Director

Mr. Christopher J. Waddick C.A., C.M.A., CPA, MBA

CFO, Corporate Secretary & Director

Mr. Bernard Lim B.Sc.

Chief Operating Officer

Dr. Andrew Warwick Hamer M.D.

Chief Medical Officer and Head of Research & Development

FAQs

What is Cardiol Therapeutics share price today?

Cardiol Therapeutics share price today is $1.12 as on at the close of the market. Cardiol Therapeutics share today touched a day high of $1.17 and a low of $1.10.

What is the 52 week high and 52 week low for Cardiol Therapeutics share?

Cardiol Therapeutics share touched a 52 week high of $2.34 on and a 52 week low of $0.88 on . Cardiol Therapeutics stock price today i.e. is closed at $1.12,which is 52.14% down from its 52 week high and 27.27% up from its 52 week low.

What is Cardiol Therapeutics's market capitalisation today?

Cardiol Therapeutics market capitalisation is $0.00T as on .

How to invest in Cardiol Therapeutics Stock (CRDL) from India?

  1. Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
  2. Step 2: Search for Cardiol Therapeutics on INDmoney app. Click on Buy button.

What is the minimum amount required to buy Cardiol Therapeutics Stock (CRDL) from India?

Indian investors can start investing in Cardiol Therapeutics (CRDL) shares with as little as ₹94.94999694824219 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹949.50 in Cardiol Therapeutics stock (as per the Rupee-Dollar exchange rate as on ). Based on Cardiol Therapeutics share’s latest price of $1.12 as on October 31, 2026 at 1:29 am IST, you will get 8.9286 shares of Cardiol Therapeutics. Learn more about fractional shares .

What are the returns that Cardiol Therapeutics has given to Indian investors in the last 5 years?

Cardiol Therapeutics stock has given -67.68% share price returns and 27.1% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?